Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 2Recruiting 2Withdrawn 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 23OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Dermatologic 1

Conditions

Breast Neoplasms 15Neoplasms 12Carcinoma, Hepatocellular 12Uterine Cervical Neoplasms 10Esophageal Neoplasms 10Nasopharyngeal Carcinoma 8Carcinoma, Non-Small-Cell Lung 8Ovarian Neoplasms 6Carcinoma, Ovarian Epithelial 6Melanoma 5Lung Neoplasms 5Colorectal Neoplasms 5Thyroid Cancer, Papillary 4Stomach Neoplasms 4Small Cell Lung Carcinoma 4Prostatic Neoplasms 4Motor Activity 4Hematologic Neoplasms 4Fallopian Tube Neoplasms 4Esophageal Squamous Cell Carcinoma 4Endometrial Neoplasms 4Colonic Neoplasms 4Triple Negative Breast Neoplasms 3Rectal Neoplasms 3Pain 3Lymphoma, Non-Hodgkin 3Lymphoma, Follicular 3Uveal Melanoma 2Thyroid Neoplasms 2Skin Neoplasms 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER_GOV × Kidney Neoplasms × Clear all
NCT06670300 2024-11-01

Clinical Observation on the Safety and Efficacy of Cardonilmab in the Treatment of Second-line and Above Advanced Melanoma and Advanced Renal Cancer

Henan Cancer Hospital

Phase 2 Not yet recruiting
20 enrolled
DermatologicGenitourinary

Kidney Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡